The Biology of Polyps: Subtypes and Pathways
At a Glance
Colon adenoma subtype, size, number, and dysplasia grade help estimate future risk and guide follow-up colonoscopy. Tubular, villous, tubulovillous, and serrated lesions have different appearances and biology, while molecular pathways usually do not determine routine surveillance intervals.
While the word “polyp” describes the physical shape of a growth in your colon, the true story of your health is found in its biology. When a pathologist looks at your polyps under a microscope, they are looking for specific architectural patterns and cellular changes. Understanding these details helps your care team determine how often you need screening and which prevention strategies are most important for you.
Architectural Subtypes: The Shape of the Cells
The architecture of an adenoma refers to how the cells are arranged as they grow. This is one of the primary ways doctors categorize your risk [1].
- Tubular Adenoma: This is the most common subtype. Under a microscope, the cells form small, tube-like structures [2]. These are generally considered the lowest-risk subtype, especially when they are small (under 10mm) [3].
- Villous Adenoma: These growths have long, finger-like projections (resembling the “villi” in your small intestine). Villous architecture is considered a high-risk or advanced histology feature [1].
- Tubulovillous Adenoma: As the name suggests, this is a hybrid growth containing both tubular and villous patterns. Because it contains villous features, it is also typically categorized as high-risk [1][4].
While villous architecture is a “yellow flag,” its risk is often tied to the size of the polyp; larger polyps (over 10mm) are much more likely to show these advanced patterns [5].
Dysplasia: The Grade of Abnormality
Dysplasia is a term that describes how abnormal and disorganized the cells appear compared to healthy colon tissue. It is not cancer, but it is the defining feature of a precancerous growth [6].
- Low-Grade Dysplasia (LGD): Most adenomas have low-grade dysplasia. The cells look different from normal cells, but they still maintain some of their original structure and organization [3].
- High-Grade Dysplasia (HGD): This is a more advanced stage of change. The cells look very abnormal and have lost much of their orderly structure. While HGD is still not invasive cancer, it indicates a “faster” or more advanced precancerous state [7].
If your report mentions HGD, it typically means your doctor will recommend more frequent follow-up colonoscopies (often every 3 years) because these lesions have a higher chance of being associated with advanced growths in the future [7][4].
Why Subtypes Matter for Your Care
Your pathology report is essentially a risk-assessment tool. If you have a single, small tubular adenoma with low-grade dysplasia, your risk is very low, and you may not need another colonoscopy for 7 to 10 years [3]. However, if your report shows villous architecture, high-grade dysplasia, or serrated features, your doctor will likely bring you back sooner (depending on size, number, and type) to ensure no new high-risk growths have formed [4][8]. Finding and removing the growths early effectively reduces risk across all types of polyps [9].
For Readers Who Want More Detail: Molecular Pathways
Note: Genetic or molecular pathway testing is not usually what determines your routine surveillance intervals—your intervals are based on the size, number, dysplasia, completeness of removal, and quality of the exam. The information below is purely for understanding the underlying biology.
Scientists have identified two main molecular pathways that most precancerous colon polyps follow.
1. The Conventional Pathway (APC/WNT)
This is the “classic” route that roughly 70% to 90% of colon cancers follow [10].
- The Spark: It usually begins with a mutation in the APC gene, which acts like a “brake” on cell growth. When this brake is broken, the WNT signaling pathway is turned on, causing cells to multiply [10].
- The Progression: Over years, other mutations (like KRAS or TP53) may occur, gradually pushing the tubular or villous adenoma toward a cancerous state [10][11].
2. The Serrated Pathway (BRAF/Methylation)
In the last two decades, doctors have identified a second, distinct pathway that involves “serrated” polyps—named because their edges look like the teeth of a saw under a microscope [12]. Sessile serrated lesions (SSLs) and traditional serrated adenomas (TSAs) are distinct lesion categories, not just tubular or villous subtypes.
- The Spark: This pathway often starts with a mutation in the BRAF or KRAS genes [12].
- The Mechanism: In addition to mutations, these cells often use methylation (a chemical “off switch”) to silence important protective genes like MLH1, though this does not occur in every serrated lesion [13][14].
- The Challenge: Serrated polyps (such as Sessile Serrated Lesions or SSLs) can be flat and pale, making them harder for doctors to see during a colonoscopy [15]. Note: “Sessile” usually describes a broad-based attachment (flat), while “Sessile Serrated Lesion” is a specific histologic diagnosis. This is why high-quality bowel preparation is so vital—it ensures your doctor can spot these subtle growths [16].
Common questions in this guide
What is the difference between tubular, tubulovillous, and villous adenomas?
Does high-grade dysplasia mean that my colon polyp is cancer?
How do polyp size and pathology affect my next colonoscopy?
What are serrated polyps, and why does bowel preparation matter?
Do APC, KRAS, BRAF, or WNT pathway findings determine my surveillance schedule?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.What architectural subtype (tubular, tubulovillous, or villous) was listed for each of my polyps?
- 2.Did any of my polyps show 'high-grade dysplasia' or signs of 'intramucosal carcinoma'?
- 3.Were any of the growths classified as 'serrated' (SSLs or TSAs) rather than conventional adenomas?
- 4.Does my pathology report mention any 'sessile' (flat) features that might have made the polyps harder to remove?
- 5.Based on my specific subtypes and genetic pathways (like APC vs. BRAF), how does this change my surveillance timeline?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (16)
- 1
Long-term cumulative incidence of metachronous advanced colorectal neoplasia after colonoscopy and a novel risk factor: a cohort study.
Omata F, Deshpande GA, Suzuki H, et al.
European journal of gastroenterology & hepatology 2021; (33(11)):1341-1347 doi:10.1097/MEG.0000000000002259.
PMID: 34402471 - 2
Curriculum review: serrated lesions of the colorectum.
Dhillon AS, Ibraheim H, Green S, et al.
Frontline gastroenterology 2020; (11(3)):243-248 doi:10.1136/flgastro-2018-101153.
PMID: 32419916 - 3
Post-polypectomy surveillance colonoscopy: Comparison of the updated guidelines.
Abu-Freha N, Katz LH, Kariv R, et al.
United European gastroenterology journal 2021; (9(6)):681-687 doi:10.1002/ueg2.12106.
PMID: 34077635 - 4
A survey of current practices in post-polypectomy surveillance in Korea.
Kim J, Gweon TG, Kwak MS, et al.
Intestinal research 2024; (22(2)):186-207 doi:10.5217/ir.2023.00109.
PMID: 38720467 - 5
High risk features in colorectal adenomatous polyps: A multi-institutional study.
Lee M, Ko HM, Kudose S, et al.
Annals of diagnostic pathology 2024; (72()):152323 doi:10.1016/j.anndiagpath.2024.152323.
PMID: 38733674 - 6
Perianal Paget disease associated with non-invasive colorectal adenoma.
Zuo Z, Wu W, Li X, et al.
Journal of cutaneous pathology 2023; (50(1)):35-38 doi:10.1111/cup.14314.
PMID: 35980771 - 7
Long term outcomes of colon polyps with high grade dysplasia following endoscopic resection.
Chang JJ, Chien CH, Chen SW, et al.
BMC gastroenterology 2020; (20(1)):376 doi:10.1186/s12876-020-01499-2.
PMID: 33172387 - 8
Surveillance after colorectal polyp resection.
Baile-Maxía S, Jover R
Best practice & research. Clinical gastroenterology 2023; (66()):101848 doi:10.1016/j.bpg.2023.101848.
PMID: 37852710 - 9
Screening Relevance of Sessile Serrated Polyps.
Kahi CJ
Clinical endoscopy 2019; (52(3)):235-238 doi:10.5946/ce.2018.112.
PMID: 30625264 - 10
The role of APC in WNT pathway activation in serrated neoplasia.
Borowsky J, Dumenil T, Bettington M, et al.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2018; (31(3)):495-504 doi:10.1038/modpathol.2017.150.
PMID: 29148535 - 11
From Crypts to Cancer: A Holistic Perspective on Colorectal Carcinogenesis and Therapeutic Strategies.
Gharib E, Robichaud GA
International journal of molecular sciences 2024; (25(17)) doi:10.3390/ijms25179463.
PMID: 39273409 - 12
Molecular and histologic considerations in the assessment of serrated polyps.
Yang HM, Mitchell JM, Sepulveda JL, Sepulveda AR
Archives of pathology & laboratory medicine 2015; (139(6)):730-41 doi:10.5858/arpa.2014-0424-RA.
PMID: 26030242 - 13
CpG Island Methylator Phenotype-High Colorectal Cancers and Their Prognostic Implications and Relationships with the Serrated Neoplasia Pathway.
Rhee YY, Kim KJ, Kang GH
Gut and liver 2017; (11(1)):38-46 doi:10.5009/gnl15535.
PMID: 27885175 - 14
Microsatellite instability in colorectal cancer.
Nojadeh JN, Behrouz Sharif S, Sakhinia E
EXCLI journal 2018; (17()):159-168 doi:10.17179/excli2017-948.
PMID: 29743854 - 15
Endoscopic diagnosis of sessile serrated adenoma/polyp with and without dysplasia/carcinoma.
Murakami T, Sakamoto N, Nagahara A
World journal of gastroenterology 2018; (24(29)):3250-3259 doi:10.3748/wjg.v24.i29.3250.
PMID: 30090005 - 16
Optimizing post-polypectomy surveillance: A practical guide for the endoscopist.
Bogie R, Sanduleanu S
Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society 2016; (28(3)):348-59 doi:10.1111/den.12510.
PMID: 26179809
This page explains colon adenoma subtypes, dysplasia, and molecular pathways for informational purposes only and does not constitute medical advice. Your gastroenterologist and pathologist can interpret your report and recommend the right follow-up schedule.
Get notified when new evidence is published on colon adenoma.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.